Literature DB >> 9795362

Retinoic acid stimulates IGF binding protein (IGFBP)-6 and depresses IGFBP-2 and IGFBP-4 in SK-N-SH human neuroblastoma cells.

D Chambéry1, B de Gallé, S Babajko.   

Abstract

Insulin-like growth factors (IGF-I and IGF-II) stimulate proliferation and differentiation in many cell types. In biological fluids, they associate non-covalently with high-affinity binding proteins (IGFBPs) which control their bioavailability and modulate their action. We previously demonstrated that IGFBP-2, -4 and -6 are intimately involved in the growth of cells derived from human neuroblastomas. Here, we have investigated the effects of retinoic acid (RA), which induces differentiation in these cells, on the expression of IGFBPs secreted by SK-N-SH neuroblastoma cells. Analysis of transcriptional activity of the IGFBP-2, -4 and -6 genes in isolated nuclei (run-on experiments) showed that RA increased the transcriptional activity of the IGFBP-6 gene, reduced that of the IGFBP-4 gene and had no effect on that of the IGFBP-2 gene. Northern blot analysis following treatment with actinomycin D showed that RA increased the stability of IGFBP-6 mRNA by a factor of 2.6, decreased that of IGFBP-2 mRNA by a factor of 2.3 and failed to affect IGFBP-4 mRNA. Treatment of cells with cycloheximide indicated the involvement of labile proteins in the stabilization of these mRNAs the expression of which could be under the control of RA. The transcriptional and/or post-transcriptional mechanisms by which RA regulates each of the IGFBPs produced by SK-N-SH cells are therefore different. Such regulation may also reflect the state of differentiation of the neuroblastoma cells. With RA-induced differentiation, IGFBP-6 is strongly stimulated, whereas IGFBP-2 and IGFBP-4 are severely depressed, which would suggest that each IGFBP plays a specific role. Moreover, this regulation seems tissue-specific because it is different in other cell types.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9795362     DOI: 10.1677/joe.0.1590227

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  4 in total

1.  Disease evidence for IGFBP-2 as a key player in prostate cancer progression and development of osteosclerotic lesions.

Authors:  David J Degraff; Adam A Aguiar; Robert A Sikes
Journal:  Am J Transl Res       Date:  2009-01-20       Impact factor: 4.060

2.  Cerebral gene expression and neurobehavioural development after perinatal exposure to an environmentally relevant polybrominated diphenylether (BDE47).

Authors:  Marte Haave; Kristin Ingvaldsen Folven; Thomas Carroll; Chris Glover; Einar Heegaard; Trond Brattelid; Christer Hogstrand; Anne-Katrine Lundebye
Journal:  Cell Biol Toxicol       Date:  2011-06-02       Impact factor: 6.691

3.  Insulin-like growth factor binding protein-6 delays replicative senescence of human fibroblasts.

Authors:  Lucia Micutkova; Thomas Diener; Chen Li; Adelina Rogowska-Wrzesinska; Christoph Mueck; Eveline Huetter; Birgit Weinberger; Beatrix Grubeck-Loebenstein; Peter Roepstorff; Rong Zeng; Pidder Jansen-Duerr
Journal:  Mech Ageing Dev       Date:  2011-07-24       Impact factor: 5.432

4.  Insulin-Like Growth Factor Binding Protein 6 Is Secreted in Extracellular Vesicles upon Hyperthermia and Oxidative Stress in Dendritic Cells But Not in Monocytes.

Authors:  Massimo Conese; Lorenzo Pace; Nicoletta Pignataro; Lucia Catucci; Antonio Ambrosi; Sante Di Gioia; Nicola Tartaglia; Arcangelo Liso
Journal:  Int J Mol Sci       Date:  2020-06-22       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.